STE
$186.42
Steris
($1.12)
(.60%)
STE
Earnings Whisper ®
N/A
2nd Quarter September 2020
Consensus:  $1.24
Revenue:  $705.25 Mil
Monday
Nov 2
4:30 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when STE reports earnings?
Beat
Meet
Miss

Where is STE's stock price going from here?
Up
Flat
Down
Stock chart of STE
Analysts
Summary of analysts' recommendations for STE
Score
Grade
Pivots
Resistance
$190.20
$188.39
$187.40

$185.59

Support
$184.61
$182.80
$181.81
Tweet
Growth
Description
Steris Plc provide infection prevention, contamination control, microbial reduction, and procedural support products and services for healthcare, pharmaceutical, scientific, research, industrial and governmental customers. The Company's operating segments consists of Healthcare, Life Sciences and STERIS Isomedix Services. Healthcare segment manufactures and sells capital equipment, accessory, consumables, information support and service solutions to healthcare providers, including acute care hospitals and surgery and gastrointestinal centers. Life Sciences segment manufactures and sells a range of capital equipment, formulated cleaning chemistries and service solutions to pharmaceutical companies and private and public research facilities. Isomedix segment sells an array of contract processing services as well as laboratory testing services. Steris Plc, formerly known as STERIS Corporation, is headquartered in Leicester, United Kingdom.
Peers
Edwards LifesciencesIntuitive SurgicalAlign TechnologyWright Medical GroupCryoLifeLakeland IndustriesInvacare